ABILITY PHARMA Trademark

Trademark Overview

On Monday, September 30, 2024, a trademark application was filed for ABILITY PHARMA with the United States Patent and Trademark Office. The USPTO has given the ABILITY PHARMA trademark a serial number of 79416504. The federal status of this trademark filing is ACTION CONTINUING FINAL - MAILED as of Wednesday, July 1, 2026. This trademark is owned by ABILITY PHARMACEUTICALS, S.A.. The ABILITY PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological research activities for development of new drugs and medicines; Technical consultancy in the field of pharmaceutical studies, in particular relating to evaluations, estimates, and reports prepared in the course of scientific and technological research in the field of pharmaceutical medicines; Industrial analysis, namely, analysis of pharmacokinetics, pharmacodynamics and biomarkers related to drugs and medicines or pathologies to assure compliance with industry standards; Industrial research in the field of medicine
ability pharma

General Information

Serial Number79416504
Word MarkABILITY PHARMA
Filing DateMonday, September 30, 2024
Status649 - ACTION CONTINUING FINAL - MAILED
Status DateWednesday, July 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"PHARMA"
Goods and ServicesScientific and technological research activities for development of new drugs and medicines; Technical consultancy in the field of pharmaceutical studies, in particular relating to evaluations, estimates, and reports prepared in the course of scientific and technological research in the field of pharmaceutical medicines; Industrial analysis, namely, analysis of pharmacokinetics, pharmacodynamics and biomarkers related to drugs and medicines or pathologies to assure compliance with industry standards; Industrial research in the field of medicine

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameABILITY PHARMACEUTICALS, S.A.
Party Type10 - Original Applicant
Legal Entity Type85 - NOT AVAILABLE
AddressES

Trademark Events

Event DateEvent Description
Thursday, February 6, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, February 19, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, February 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 21, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, March 19, 2025ASSIGNED TO EXAMINER
Monday, March 24, 2025NON-FINAL ACTION WRITTEN
Tuesday, March 25, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 16, 2025REFUSAL PROCESSED BY MPU
Saturday, May 17, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 7, 2025REFUSAL PROCESSED BY IB
Monday, October 20, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 20, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 19, 2025FINAL REFUSAL WRITTEN
Wednesday, November 19, 2025FINAL REFUSAL E-MAILED
Wednesday, November 19, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, January 1, 2026LIMITATION OF GOODS RECEIVED FROM IB
Thursday, February 12, 2026LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, May 12, 2026TEAS REQUEST TO DIVIDE RECEIVED
Monday, May 18, 2026EXPARTE APPEAL RECEIVED AT TTAB
Monday, May 18, 2026JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, May 18, 2026EX PARTE APPEAL-INSTITUTED
Monday, May 18, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, May 20, 2026ASSIGNED TO LIE
Monday, June 22, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 12, 2026DIVISIONAL REQUEST RECEIVED
Monday, June 22, 2026DIVISIONAL PROCESSING COMPLETE
Wednesday, July 1, 2026ACTION CONTINUING FINAL - COMPLETED
Wednesday, July 1, 2026ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, July 1, 2026NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Sunday, July 5, 2026NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, July 6, 2026NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Related Keywords

pharma ability medicines research field scientific analysis pharmaceutical technological drugs industrial pharmacodynamics